| Azzoli CG, Baker S, Temin S, et al.
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Elbahaie AM, Kamel DE, Lawrence J, et al.
Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature. [JOURNAL ARTICLE]
World J Surg Oncol 2009 Nov 9; 7(1):84.
Abstract | Full Citation | | Vrouchou P, Kandaswamy P, George E, et al.
Pemetrexed approved for the fi rst-line treatment of non-small-cell lung cancer: summary of the NICE appraisal. [News]
Lancet Oncol 2009 Nov; 10(11):1031-2.
Full Citation | | Ceresoli GL, Zucali PA, Gianoncelli L, et al.
Second-line treatment for malignant pleural mesothelioma. [JOURNAL ARTICLE]
Cancer Treat Rev 2009 Oct 28.
Abstract | Full Citation | | Baldwin CM, Perry CM
Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer. [Journal Article]
Drugs 2009; 69(16):2279-302.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ricciardi S, Tomao S, de Marinis F
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer. [Journal Article]
Ther Clin Risk Manag 2009.:781-7.
Abstract | Full Citation | | Karapanagiotou EM, Boura PG, Papamichalis G, et al.
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study. [Journal Article]
Anticancer Res 2009 Oct; 29(10):4297-301.
Abstract | Full Citation | Find Related Articles | | Adjei AA, Mandrekar SJ, Dy GK, et al.
Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non-Small-Cell Lung Cancer: NCCTG and SWOG Study N0426. [JOURNAL ARTICLE]
J Clin Oncol 2009 Oct 19.
Abstract | Full Citation | Find Related Articles | | Konopa K, Jassem J
The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Curr Drug Targets 2009 Sep 19.
Abstract | Full Citation | Find Related Articles | | Giovannetti E, Honeywell R, Hanauske AR, et al.
Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC). [JOURNAL ARTICLE]
Curr Drug Targets 2009 Sep 19.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
